Inventor
KOVALEVSKI-ISHAI ETI
IL22 patents
⚠️ This page may combine multiple inventors who share the name “KOVALEVSKI-ISHAI ETI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VASCULAR BIOGENICS LTD
13 patentsUS7973023B2Jul 5, 2011
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
VASCULAR BIOGENICS LTD31 citations96
US7902176B2Mar 8, 2011
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
VASCULAR BIOGENICS LTD31 citations96
US7893291B2Feb 22, 2011
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD24 citations96
US7625882B2Dec 1, 2009
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
VASCULAR BIOGENICS LTD31 citations96
US7504388B2Mar 17, 2009
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD31 citations96
US6838452B2Jan 4, 2005
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
VASCULAR BIOGENICS LTD62 citations96
US7807847B2Oct 5, 2010
Process for the preparation of oxidized phospholipids
VASCULAR BIOGENICS LTD17 citations92
US9566288B2Feb 14, 2017
High-purity phospholipids
VASCULAR BIOGENICS LTD5 citations84
US9006217B2Apr 14, 2015
High-purity phospholipids
VASCULAR BIOGENICS LTD5 citations84
US8802875B2Aug 12, 2014
Process for the preparation of oxidized phospholipids
VASCULAR BIOGENICS LTD5 citations84
US8759557B2Jun 24, 2014
Process for the preparation of oxidized phospholipids
VASCULAR BIOGENICS LTD4 citations84
US8569529B2Oct 29, 2013
High-purity phospholipids
VASCULAR BIOGENICS LTD8 citations84
US9968622B2May 15, 2018
High-purity phospholipids
VASCULAR BIOGENICS LTD2 citations73
HARATS DROR
3 patentsUS8563534B2Oct 22, 2013
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
HARATS DROR8 citations92
US8158611B2Apr 17, 2012
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
HARATS DROR18 citations92
US8501715B2Aug 6, 2013
Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
HARATS DROR8 citations83
TEVA PHARMA
3 patentsUS6992194B2Jan 31, 2006
Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
TEVA PHARMA16 citations92
US7074928B2Jul 11, 2006
Polymorphs of clopidogrel hydrogensulfate
TEVA PHARMA26 citations91
US6767913B2Jul 27, 2004
Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
TEVA PHARMA46 citations89